Medicine
Zolymbus 0.01% ophthalmic gel
Zolymbus 0.01% ophthalmic gel is a prescription medicine containing Bimatoprost for ophthalmic use, marketed by Thea Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 30°C (68°F to 86°F). After the pouch is opened, the…
Key facts
- Active ingredient (INN)
- Bimatoprost
- Brand
- Zolymbus
- Strength
- 0.01%
- Dosage form
- Ophthalmic gel
- Route
- Ophthalmic
- Packs
- 3 pouches
- Marketing authorisation holder
- Thea Pharma
- Manufacturer
- Thea Pharma
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 30°C (68°F to 86°F). After the pouch is opened, the single-dose containers may be stored in the opened foil pouch for up to 14 days at 20°C to 30°C (68°F to 86°F). Protect from light. Store in the original pouch.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EE03 Bimatoprost
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 February 2026
- Identifiers
- RxCUI 2725168, 2725620DailyMed set ID f4504a0c-7998-4084-9e05-f999f1d051edNDC 82584-010Application NDA217307
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 3 pouch in 1 carton / 10 vial, single-dose in 1 pouch / .3 g in 1 vial, single-dose | 82584-010-30 | Thea Pharma | 26 February 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Bimatoprost
Clinical summary
Bimatoprost is a prostaglandin analog indicated to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness. It is available as eye drops, implants and ophthalmic gel for intracameral use. MedsAcross supplies Bimatoprost for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BimatoprostFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- LATISSE prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
- Lumigan: European public assessment report (EPAR) · European Medicines Agency
Need Zolymbus 0.01% ophthalmic gel for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.